[17] A pharmacist seeking authority for initial prescribing privileges must complete a detailed application assessed through a standardized evaluation process described elsewhere.[17] Internationally, numerous models for pharmacist prescribing have been proposed. These are described in Table 5[17–21] which includes status of implementation. Adapting a prescription includes altering a dose during the process of dispensing, thus enabling the pharmacist Veliparib manufacturer to respond to patient-specific needs such as organ function or allergy status.

All pharmacists on the clinical register with ACP are permitted to adapt a prescription; initially authority was granted subsequent to completing an education programme about prescription adapting including regulatory requirements for doing so. The new regulation does not include direct consideration related to the proposal for comprehensive drug-therapy management. This aspect of the proposal reflected the pharmacists’ ability to manage ongoing therapy which may include assessment of therapy, adjusting doses selleck inhibitor or adding new therapies to the regimen when appropriate. This omission may have been in acknowledgement of the concerns

raised by physicians about pharmacists’ role as clinicians.[14] However, it ultimately is a moot point as the ability to provide this level of care falls under the privileges within the initial prescribing authority. While

not specifically stated in the regulations, in response to stakeholder concerns, pharmacists have been advised that they should not prepare for sale, prescriptions which they have written. ACP does not support payment, or the appearance of payment, for prescribing Low-density-lipoprotein receptor kinase (G Eberhart, personal communication, March 2007). To date there has been no formal evaluation of the effects of this legislation change. The following information describes current impacts of the implementation of this legislation. On 2 September 2010, 100 pharmacists had been successful in their application for initial prescribing authority.[22] By June 2009, all pharmacists registered in Alberta (approximately 4000) had completed the required education programme necessary for prescribing to adapt a prescription or for prescribing in an emergency (D Cooney, personal communication, September 2010). Claims data from Alberta Blue Cross, a public and private health plan which includes drug coverage for senior citizens and social services clients, showed that between 1 April and 30 September 2007, 2173 pharmacists prescribed at least one prescription with just over 65 000 prescriptions claimed for during this period.